Delivery Order SPE2DB24D1205-SPE2DB25FCWPH

Award Date 5/7/25
Potential Completion Date 5/29/25
Potential Value $6.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB22D3004 | SPE2DB25FPS01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYEPTI 100 MG/ML VIALML, a pharmaceutical product, and has a ceiling value of $5,785.90. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 19, 2025. The contract does not...
This federal contract award, with the ID SPE2DB24D1205|SPE2DB25FCVMX, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,943.08 Firm Fixed Price delivery order is for the supply of VYEPTI 100 MG/ML VIALML, a medical product, to support military healthcare programs. The contract has an ultimate completion date of April 24, 2025 and does not have a set-aside designation, indicating open...
This contract award, valued at $5,785.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of VYEPTI 100 MG/ML vials, a prescription medication, with a completion date of January 28, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,943.08, is for the delivery of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The contract has a firm fixed price, and the ultimate completion date is April 14, 2025. The contract is a delivery order and was awarded on March 24, 2025. The place of performance is Conshohocken, PA. This award is...
This federal contract award, identified as SPE2DB24D1205|SPE2DB25FCSVQ, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,471.54, is for the delivery of the medication VYEPTI 100 MG/ML VIALML. This is a firm-fixed-price delivery order contract, with an ultimate completion date of January 29, 2025. The contract does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,943.08 firm fixed-price delivery order is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,313.20 firm fixed-price delivery order is for the supply of VYEPTI 100 MG/ML VIAL medication. The contract has an ultimate completion date of December 13, 2024. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,628.72, is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of February 14, 2025. The award was made on January 24, 2025, and there is no set-aside designation indicated. AmerisourceBergen holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VYEPTI 100 MG/ML VIALML. The award, valued at $42,700.40, is a firm fixed-price contract with an ultimate completion date of August 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for delivering a comprehensive range of medical commodities to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,157.18 firm fixed-price delivery order is for VYEPTI 100 MG/ML VIALML, with a period of performance through April 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCWPH
    Delivery Order

This federal contract award, with ID SPE2DB24D1205|SPE2DB25FCWPH, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VYEPTI 100 MG/ML vials, a pharmaceutical product, with a ceiling value of $6,943.08. The contract is a Firm Fixed Price Delivery Order, with a performance period ending on May 29, 2025. The award date is May 7, 2025, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.

Generated 8/6/25, 9:52 AM